AKT1 and Alzheimer disease: To further assess EJW’s effects on AD, components including diosgenin, baicalein, beta-sitosterol, and quercetin were docked with core target proteins (JUN, AKT1, IL1B, CASP3, VEGFA, TP53, and IL6).